van Mulligen E, Bour SS, Goossens LMA, de Jong PHP, et al. Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial. Ann Rheum Dis 2024 Sep 18:ard-2024-226286. doi: 10.1136/ard-2024-226286.
PMID: 39299721